Omkar Pharmachem Ltd Share Price

16.10

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Nov-2019 - -
OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve the Unaudited Financial Results of the Company alongwith Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the Quarter and half year ended 30th September, 2019 Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 14th November, 2019 has Considered and approved: Unaudited Financial Results of the Company along with Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the quarter and half year ended on 30th September, 2019. (As Per BSE Announcement dated on 14/11/2019) Dear Sir, Please find enclosed herewith copy of newspapers advertisement in which Unaudited financial results for the quarter and half year ended on 30th September, 2019 are published, one in vernacular language and one in English newspaper. (As per BSE Announcement Dated on 15.11.2019)
Board Meeting - 31-Aug-2019 - -
Dear Sir/Maam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) LODR Regulations, 2015, this is to inform the Exchange that the Board of Directors in its meeting held on today i.e. 31st August, 2019 has approved inter alia the following: 1. Notice of 24th Annual General Meeting of the Shareholders of the Company to be held on Saturday, 28th September, 2019 at 11:30 AM at the registered office of the Company. 2. Closure of Register of Members and share transfer books of the Company from Sunday, 22nd Day of September, 2019 to Saturday, 28th Day of September, 2019 (both days inclusive), for the purpose of Annual General Meeting of the Company. 3. Approval of Directors report along with the annexure(s) thereto for the financial year ended on 31st March 2019.
Board Meeting - 02-Aug-2019 - -
OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve Dear Sir, Pursuant to Regulations 29(1)(a) of SEBI (LODR) Regulations 2015 notice is hereby given that a meeting of Board of Directors of Omkar Pharmachem Limited will be held on Wednesday, 14th August, 2019 at 04:30 P.M. at the registered office of the Company inter alia; To consider, approve and take on record the Unaudited Financial Results of the Company for the Quarter ended 30th June, 2019 Further, in continuation to our Intimation dated July 1, 2019 regarding closure of trading window for dealing in shares of the Company, we hereby inform you that pursuant to the Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company, the trading window for dealing in shares of the Company shall continue to remain closed till August 16, 2019 (inclusive), for all the Designated Persons of the Company and their Immediate Relatives. Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 14th August, 2019 has Considered and approved: 1) Unaudited Financial Results of the Company for the quarter ended on 30th June, 2019 along with Limited Review Report of the Company. Dear Sir, Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please find enclosed herewith: Unaudited Financial Results of the Company, for the Quarter ended on 30th June, 2019, along with the Limited Review Report of the Company. The aforesaid result has been approved by the Board of Directors at their meeting held on 14th August, 2019. (As Per BSE Announcement Dated 14.08.2019)
Board Meeting - 20-May-2019 - -
OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve To consider, approve and take on record the Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2019 Further, in continuation to our Intimation dated April 4, 2019 regarding closure of trading window for dealing in shares of the Company, we hereby inform you that pursuant to the Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company, the trading window for dealing in shares of the Company shall continue to remain closed till June 1, 2019 (inclusive), for all the Designated Persons of the Company and their Immediate Relatives. Dear Sir, Please find enclosed herewith copy of newspapers, one in vernacular language and one in English, in which advertisement for convening the Board Meeting, to consider, approve and take on record the Audited financial results for the quarter and financial year ended on 31st March, 2019, pursuant to regulation 33 of the of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 has been given. (As Per BSE Announcement Dated 21.05.2019) Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 30th May, 2019 has Considered and approved: 1)Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2019 along with Auditors Report on Audited Financial Results by Statutory auditor of the Company and Statement of Asset and Liabilities of the Company. 2)Declaration under Regulation 33(3)(d) of SEBI (Listing Obligations and Discloser Requirement) Regulation 2015. Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please find enclosed herewith: 1.Audited Financial Results of the Company, for the Quarter and Financial year ended on 31st March, 2019, alongwith the Auditors Report on Audited Financial results by statutory auditor of the Company. 2.Statement of Asset and Liabilities of the Company. 3.Declaration under Regulation 33(3)(d) of SEBI (Listing Obligations and Discloser Requirement) Regulation 2015. The aforesaid result has been approved by the Board of Directors at their meeting held on 30th May, 2019. (As Per BSE Announcement Dated 30.05.2019)
Board Meeting - 04-Feb-2019 - -
OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve To consider, approve and take on record the Unaudited Financial Results for the Quarter ended on 31st December, 2018 along with Limited Review Report. Dear Sir, Please find enclosed herewith copy of newspapers, one in vernacular language and one in English, in which advertisement for convening the Board Meeting, to consider, approve and take on record the Unaudited financial results for the quarter ended on 31st December, 2018, pursuant to regulation 33 of the of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 has been given. (As Per BSE Announcement Dated On 05/02/2019) Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 14th February, 2019 has Considered and approved the following items: 1)Unaudited Financial Results for the quarter and Nine Months ended on 31st December, 2018 along with Limited Review Report Dear Sir, Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please find enclosed herewith: 1. Unaudited Financial Results of the Company, for the Quarter and Nine Months ended on 31st December, 2018, along with Limited Review Report. The aforesaid result has been approved by the Board of Directors at their meeting held on 14th February, 2019. (As Per BSE Announcement Dated 14.02.2019)